The Rise of Medical Travel to China: What the 2025–2026 Boom Means for International Patients
International patient visits to Chinese hospitals surged 73.6% in three years. Here's what's driving the trend — from visa-free policies to real patient stories — and what it means for you.
Something unexpected happened during the "China Travel" wave of 2025. Foreign visitors started posting about something nobody expected: their medical experiences.
A South Korean blogger filmed his wrist tenosynovitis — which had bothered him for three years despite failed surgery attempts in Korea costing over 1 million KRW — being treated in China in 30 seconds for about 20,000 KRW. A South African visitor shared that an MRI in Yunnan cost 486 RMB (roughly $67), compared to thousands of dollars back home. A British patient who had been waiting 26 weeks for an MRI referral in the NHS got one done in China the same day.
These weren't isolated incidents. They were part of a shift that caught the attention of hospitals, policymakers, and patients worldwide. International medical travel to China isn't just growing — it's accelerating faster than almost anyone predicted.
The Numbers Tell the Story
According to the National Health Commission's 2025 annual report, key Chinese hospitals recorded 1.28 million international patient visits in 2025 — a 73.6% increase from three years earlier. Across the country, 850 medical institutions in 57 cities now offer international medical services.
The growth is broad-based:
| Source Region | Trend |
|---|---|
| Southeast Asia | 150,000+ patients/year traveling to China for treatment |
| Europe & Americas | Patient numbers doubled year-over-year |
| Middle East | Significant growth in families seeking long-term pediatric care |
| Hong Kong & Macao | Seamless cross-border care via Greater Bay Area integration |
Individual hospitals are seeing the surge firsthand. HKU-Shenzhen Hospital has treated patients from 129 countries and regions. Guangzhou Fosun Chancheng Hospital saw approximately 2,000 international patients from over 30 countries in 2025 alone, with Bangladesh as the single largest source country.
Perhaps most striking is the Boao Lecheng Pilot Zone in Hainan — China's dedicated medical tourism special zone — which received 860,000 medical tourism visits in 2025, generating 8.39 billion RMB in revenue, a 51.5% year-over-year increase.
Policy Tailwinds: What Changed?
Several policy shifts in 2025–2026 are making it easier than ever for international patients to access Chinese healthcare.
Visa-Free Entry and Transit Exemptions
Citizens of over 50 countries can now enter China visa-free for up to 30 days, and medical treatment is an explicitly permitted purpose. The 240-hour transit visa exemption also enables stopover consultations — a patient from Europe or Southeast Asia can fly into a major Chinese city, have a specialist consultation, and continue their journey.
Greater Bay Area: A Living Laboratory
The Guangdong–Hong Kong–Macao Greater Bay Area has become the vanguard of cross-border healthcare integration:
- "港澳药械通" (Hong Kong-Macao Drug and Device Access): 34 internationally approved drugs and 18 medical devices — not yet available on the mainland — have been imported, benefiting over 7,500 patients at HKU-Shenzhen Hospital alone
- Cross-border health records: Hong Kong's 6.3 million eHealth users can now access their electronic health records when receiving care in Shenzhen
- Doctor mutual recognition: Nearly 100 Hong Kong-licensed doctors practice at HKU-Shenzhen Hospital, with 37 holding senior specialist titles
Government-Level Support
China's 2026 Government Work Report explicitly called for "optimizing the inbound consumption environment", and cities are responding. Guangzhou is preparing 12 specific policies to support international medical services. Guangdong province is launching an "International Medical Service Pilot" designation for qualifying hospitals.
The Remaining Gap: No Dedicated Medical Visa
Despite these advances, China has not yet established a dedicated medical visa category. Foreign patients currently use tourist visas or short-term private visit visas (S2), which may not provide sufficient duration for long-term treatments. Dr. Pan Zhongying, CEO of Beijing United Family Hospital, has publicly called for a medical-specific visa framework, noting that her hospital has treated Middle Eastern pediatric patients requiring months of care — each visa expiration requiring a renewal process that disrupts treatment.
This gap is widely expected to be addressed as the industry matures.
Real Patients, Real Stories
Behind the statistics are people who made the decision to travel across the world for care. Their experiences reveal what's driving — and sometimes complicating — this trend.
The "Price Comparison" Wave
Foreign patients are doing something unprecedented: publicly comparing healthcare costs and wait times between China and their home countries. Chinese social media platforms like Xiaohongshu and international platforms like TikTok and YouTube have become unexpected forums for healthcare transparency.
A British blogger known as Amy shared that a treatment she had been told would take 2 years and cost approximately 35,000 RMB in the UK was completed in China in 13 days for under 3,000 RMB. Her post went viral, generating thousands of comments from both Chinese and foreign users surprised by the disparity.
Building for Diversity
Hospitals are adapting to serve increasingly diverse patient populations. Guangzhou Fosun Chancheng Hospital — where Bangladesh represents 16% of international patients — has installed halal dining facilities and prayer rooms to accommodate Muslim patients from Southeast Asia and the Middle East.
At the Boao Lechinen Pilot Zone, an Indonesian medical delegation arrived in December 2024 for comprehensive health screenings and ophthalmology consultations. The zone saw inbound medical tourism surge 618.9% in the second half of 2025 alone.
Seeking Innovative Drugs
Perhaps the most compelling stories involve patients accessing treatments they literally cannot get elsewhere. At Zhongshan Ophthalmic Center in Guangzhou, Professor Lu Rong has treated patients from Germany and Thailand who traveled specifically for a domestically developed thyroid eye disease medication. The drug's self-pay cost dropped 60% after insurance coverage, bringing patient costs to roughly 10,000 RMB per course — compared to approximately $250,000 for comparable treatment in the United States.
For patients like Alex, a European multiple myeloma patient who found life-saving CAR-T therapy in Beijing, the journey to China was literally life-changing. Read Alex's complete story →
Why China? Three Clear Advantages
💰 Cost
The price differences are dramatic and consistent across nearly every category of care — from routine diagnostics to advanced therapeutics. China's domestically manufactured innovative drugs, in particular, offer world-class efficacy at a fraction of international pricing.
⚡ Speed
Where patients in many Western countries wait weeks or months for diagnostic imaging or specialist referrals, Chinese hospitals routinely deliver same-day or next-day results. For patients with serious conditions, this speed can be the difference between early intervention and disease progression.
🔬 Advanced Technology
China now accounts for over 30% of global innovative therapy pipelines. The country leads the world in CAR-T clinical trials and has rapidly developed expertise in cell therapies, targeted treatments, and domestically engineered pharmaceuticals. For many conditions, Chinese hospitals offer access to the most current treatment protocols available anywhere.
Challenges That Remain
This growth story comes with honest caveats:
- Brand awareness is low. As Cai Qiang, founder of Saint Lucia China, acknowledged: "Chinese healthcare's brand influence is still insufficient — in many countries, awareness is close to zero."
- Language barriers persist outside major international hospitals.
- The medical visa gap needs a policy solution for complex, long-term cases.
- Quality varies. While top-tier institutions are world-class, patients need guidance to identify the right hospital for their specific condition.
What This Means for You
If you're considering medical travel to China, the infrastructure and policy environment have never been more favorable. The key is having the right guidance to navigate the system.
ChinaMed Select exists for exactly this purpose — connecting international patients with China's best hospitals, handling everything from hospital matching and appointment scheduling to medical record translation and on-the-ground patient support.
Next Steps
- 📋 Complete Medical Visa Guide — everything you need to know about visa options
- 🏥 JCI-Accredited Hospitals in China — verified quality hospital listings
- 📖 Step-by-Step Hospital Visit Guide — practical preparation for your visit
- 💊 CAR-T Therapy in China: Cost & Process — treatment-specific deep dive
Ready to explore your options? Contact our medical team for a free consultation and personalized treatment plan.
Sources: China News Service (Feb 2026), Shenzhen News (Mar 2026), Guancha.cn (Jan 2026), Beijing Business Today (May 2025), National Health Commission 2025 Annual Report, Travel and Tour World (2025).